Skip to content

Clinical evaluation of fullerene scalp conditioning essence oil in improving the scalp health of patients with androgenic alopecia.

Clinical evaluation of fullerene scalp conditioning essence oil in improving the scalp health of patients with androgenic alopecia.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099129
Enrollment
Unknown
Registered
2025-03-19
Start date
2024-04-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenic Alopecia

Interventions

Experimental group:Fullerene Scalp Conditioning Essence Oil (Beijing Rensheng Zefa Biotechnology Co., Ltd., Internal Makeup 20230001, GB/T 29990 (Type II)) was applied externally, applied to the hair

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Male, age >=18 years old and <=40 years old; 2. Meet the diagnostic criteria of AGA, Hamilton-Norwood grading grade II ~ IV; 3. Scalp environmental problems, such as greasy hair, dandruff, scalp erythema, itching, odor and folliculitis and other symptoms; 4. Those who can adhere to the intervention and follow-up and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, liver and kidney diseases and mental illness; 2. Those who cannot insist on follow-up or do not sign the informed consent form; 3. Those who have used systemic or topical drugs for the treatment of hair loss within 4 weeks; 4. Those with allergies, severe allergies to the ingredients of the test products; 5. Any other condition that, in the opinion of the investigator, is not suitable to participate in this trial.

Design outcomes

Primary

MeasureTime frame
Overall hair density within the target area;Hair Growth Assessment (HGA), including participant self-assessment and investigator assessment;Changes in scalp inflammation;Scalp environment evaluation indicators (sebum, pH value, transepidermal water loss, moisture content);

Secondary

MeasureTime frame
Changes in the terminal/vellus hair ratio within the target area;Changes in the average diameter of total hair within the target area;

Countries

China

Contacts

Public ContactDingquan Yang

China-Japan Friendship Hospital

ydqlx@163.com+86 139 0121 8671

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026